Technical Analysis for AKRO - Akero Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 19.74 | 4.28% | 0.81 |
AKRO closed up 4.28 percent on Friday, April 26, 2024, on 53 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 4.28% | |
| Below Lower BB | Weakness | 4.28% | |
| Lower Bollinger Band Touch | Weakness | 4.28% | |
| Oversold Stochastic | Weakness | 4.28% | |
| Stochastic Reached Oversold | Weakness | -2.57% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 17 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
| Up 5% | about 17 hours ago |
| Up 3% | about 21 hours ago |
| Up 2% | about 21 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 58.38 |
| 52 Week Low | 11.25 |
| Average Volume | 1,412,910 |
| 200-Day Moving Average | 28.82 |
| 50-Day Moving Average | 24.58 |
| 20-Day Moving Average | 21.84 |
| 10-Day Moving Average | 20.71 |
| Average True Range | 1.30 |
| RSI (14) | 33.77 |
| ADX | 30.15 |
| +DI | 10.28 |
| -DI | 34.53 |
| Chandelier Exit (Long, 3 ATRs) | 21.52 |
| Chandelier Exit (Short, 3 ATRs) | 22.11 |
| Upper Bollinger Bands | 24.59 |
| Lower Bollinger Band | 19.08 |
| Percent B (%b) | 0.12 |
| BandWidth | 25.22 |
| MACD Line | -1.34 |
| MACD Signal Line | -1.16 |
| MACD Histogram | -0.1736 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 21.27 | ||||
| Resistance 3 (R3) | 21.18 | 20.57 | 21.02 | ||
| Resistance 2 (R2) | 20.57 | 20.18 | 20.62 | 20.93 | |
| Resistance 1 (R1) | 20.16 | 19.94 | 20.37 | 20.25 | 20.84 |
| Pivot Point | 19.55 | 19.55 | 19.66 | 19.60 | 19.55 |
| Support 1 (S1) | 19.14 | 19.16 | 19.35 | 19.23 | 18.64 |
| Support 2 (S2) | 18.53 | 18.92 | 18.58 | 18.55 | |
| Support 3 (S3) | 18.12 | 18.53 | 18.47 | ||
| Support 4 (S4) | 18.21 |
